98. 好酸球性消化管疾患 Eosinophilic gastrointestinal disease Clinical trials / Disease details

臨床試験数 : 171 / 薬物数 : 184 - (DrugBank : 47) / 標的遺伝子数 : 42 - 標的パスウェイ数 : 141

4 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01702701 (ClinicalTrials.gov)	January 2012	4/10/2012	Eosinophilic Esophagitis Treatment: Montelukast vs Fluticasone	Eosinophilic Esophagitis Treatment: Montelukast vs Fluticasone	Eosinophilic Esophagitis;Dysphagia	Drug: Montelukast;Drug: Fluticasone	Medical College of Wisconsin	NULL	Withdrawn	18 Years	N/A	All	0	Phase 3	United States
2	NCT01458418 (ClinicalTrials.gov)	December 2011	18/10/2011	A Trial of Montelukast for Maintenance Therapy of Eosinophilic Esophagitis in Children	A Trial of Montelukast for Maintenance Therapy of Eosinophilic Esophagitis in Children	Eosinophilic Esophagitis	Drug: Montelukast;Other: placebo;Drug: 5 mg Montelukast	Children's Mercy Hospital Kansas City	NULL	Terminated	2 Years	17 Years	All	4	N/A	United States
3	NCT00511316 (ClinicalTrials.gov)	August 2007	1/8/2007	Trial of Montelukast in Eosinophilic Esophagitis	A Randomized Placebo-Controlled Trial of Montelukast in Maintenance Therapy of Asymptomatic Eosinophilic Esophagitis	Eosinophilic Esophagitis	Drug: Montelukast / Singulair;Drug: Placebo	Mayo Clinic	Merck Sharp & Dohme Corp.;Merck Sharp & Dohme Corp.	Completed	18 Years	100 Years	Both	41	Phase 1	United States
4	NCT00148603 (ClinicalTrials.gov)	September 2005	6/9/2005	Montelukast in the Treatment of Duodenal Eosinophilia	Montelukast in the Treatment of Duodenal Eosinophilia in Children With Dyspepsia: Effect on Eosinophil Density and Activation in Relation to Pharmacokinetics	Eosinophilic Gastroenteritis;Dyspepsia	Drug: montelukast	Children's Mercy Hospital Kansas City	Merck Sharp & Dohme Corp.	Completed	8 Years	17 Years	Both	24	N/A	United States